tiprankstipranks
Trending News
More News >
Verve Therapeutics (VERV)
NASDAQ:VERV
US Market

Verve Therapeutics (VERV) Technical Analysis

Compare
670 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
1Neutral
6Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Verve Therapeutics’s (VERV) Moving Averages Convergence Divergence (MACD) indicator is 0.20, suggesting Verve Therapeutics is a Sell.
Verve Therapeutics’s (VERV) 20-Day exponential moving average is 4.87, while Verve Therapeutics’s (VERV) share price is $5.73, making it a Buy.
Verve Therapeutics’s (VERV) 50-Day exponential moving average is 4.95, while Verve Therapeutics’s (VERV) share price is $5.73, making it a Buy.

Verve Therapeutics (VERV) Pivot Points

Jun 07, 2025, 03:30 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.21
4.70
5.21
5.70
6.21
6.70
7.21
Fibonacci
4.70
5.08
5.31
5.70
6.08
6.31
6.70
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Verve Therapeutics (VERV) Moving Averages

Jun 07, 2025, 03:30 PM
Period
Simple
Exponential
MA5
5.37Buy
5.50Buy
MA10
4.88Buy
5.12Buy
MA20
4.62Buy
4.87Buy
MA50
4.60Buy
4.95Buy
MA100
5.75Buy
5.29Buy
MA200
5.68Buy
5.46Buy
Verve Therapeutics’s (VERV) 10-Day exponential moving average is 5.12, while Verve Therapeutics’s (VERV) share price is $5.73, making it a Buy.
Verve Therapeutics’s (VERV) 100-Day exponential moving average is 5.29, while Verve Therapeutics’s (VERV) share price is $5.73, making it a Buy.
Verve Therapeutics’s (VERV) stock price is $5.73 and Verve Therapeutics’s (VERV) 50-day simple moving average is 4.60, creating a Buy signal.
Verve Therapeutics’s (VERV) stock price is $5.73 and Verve Therapeutics’s (VERV) 100-day simple moving average is 5.75, creating a Buy signal.
Verve Therapeutics’s (VERV) stock price is $5.73 and Verve Therapeutics’s (VERV) 200-day simple moving average is 5.68, creating a Buy signal.

Verve Therapeutics (VERV) Technical Indicators

Jun 07, 2025, 03:30 PM
Name
Value
Implied Action
RSI (14)
70.23
Sell
STOCH (9,6)
85.71
Sell
STOCHRSI (14)
85.71
Sell
MACD (12,26)
0.20
Sell
ADX (14)
18.41
Buy
Williams %R
-14.13
Sell
CCI (14)
288.10
Sell
ATR (14)
0.53
-
Ultimate Oscillator
59.19
Neutral
ROC
33.91
Buy
Verve Therapeutics’s (VERV) Relative Strength Index (RSI) is 70.23, creating a Sell signal.
Verve Therapeutics’s (VERV) Trend Strength Indicator (ADX) is 18.41, creating a Buy signal.
Verve Therapeutics’s (VERV) Commodity Channel Index (CCI) is 288.10, creating a Sell signal.
Verve Therapeutics’s (VERV) Price Rate of Change (ROC) is 33.91, creating a Buy signal.

FAQ

Is VERV a Buy, Hold, or Sell?
Based on VERV’s technical indicators, VERV is a Buy.
    What is VERV’s RSI (14)?
    VERV’s RSI (14) is 70.23, which suggests VERV is a Sell.
      What is VERV’s MACD?
      VERV’s MACD is 0.20, which suggests VERV is a Sell.
        What is VERV’s 5-day moving average?
        VERV’s 5-day moving average is 5.37, which suggests VERV is a Buy.
          What is VERV’s 20-day moving average?
          VERV 20-day moving average is 4.62, which suggests VERV is a Buy.
            What is VERV’s 50-day moving average?
            VERV’s 50-day moving average is 4.60, which suggests VERV is a Buy.
              What is VERV’s 200-day moving average?
              VERV’s 200-day moving average is 5.68, which suggests VERV is a Buy.
                What is VERV’s Williams % R (14)?
                VERV’s Williams % R (14) is -14.13, which suggests VERV is a Sell.
                  What is VERV’s CCI (14)?
                  VERV’s CCI (14) is 288.10, which suggests VERV is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis